Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Researchers Push FDA To Raise Standards For Metal-On-Metal Hips

This article was originally published in The Gray Sheet

Executive Summary

Flaws in the 510(k) process prevented FDA from noticing high metal-on-metal revision rates, researchers write in the New England Journal of Medicine. Their argument is based on a predicate “ancestry” analysis of DePuy’s recalled ASR hip system.


Related Content

PMAs Are The New Reality For Metal-On-Metal Hips
Device Reg Issues In Play As FDA Kicks Off User Fee Renewal Effort
Washington Roundup, January 2013
FDA Proposes PMAs For Metal-On-Metal Hips
Metal-On-Metal Hips Get Failing Grade In New Registry Analysis
Changing The Paradigm: 510(k) Draft Guidance May Raise New Questions
J&J/DePuy Recalls ASR Hip Systems - Effort Could Cost $1.2 Bil.
FDA Device Center Gears Up For Product Reclassification Push





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts